Table 2.
Mutation | Drug |
---|---|
Flt3 | Crenolanib and quizartinib |
IDH1 | AG-120 |
IDH2 | AG-221 |
UTX | EZH2 inhibitor |
Heterozygous TET2 | 5-azacytidine/vitamin C? |
DNMT3A | S-adenosylmethionine? |
JAK2 | Ruxolitinib |
cKIT | Axitinib and dasatinib |
Del 5q | Lenalidomide |
Spliceosomal factor | H3B-8800? |
CSF3R | Ruxolitinib |
?, future potential.